SCHEMBL6687955

SCHEMBL6687955

C[C@H](NS(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1)C(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 4/20 0.52
MMP1 P03956 4/20 0.52
MMP13 P45452 4/20 0.52
MMP2 P08253 3/20 0.52
SOS1 Q07889 1/20 0.50
F2 P00734 1/20 0.49
PRSS1 P07477 1/20 0.49
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49
ST14 Q9Y5Y6 1/20 0.49
MMP3 P08254 2/20 0.49
MMP7 P09237 2/20 0.49
ADAMTS4 O75173 2/20 0.48
SLC1A3 P43003 1/20 0.48
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
FFAR1 O14842 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
SCN9A Q15858 7/20 0.47
BCL2L1 Q07817 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6687951 1.00 MMP9 (0.52) MMP9MMP1MMP13MMP2SOS1
SCHEMBL1798547 0.87 MMP9 (0.67) MMP9MMP1MMP13MMP2SOS1
SCHEMBL1798546 0.87 MMP9 (0.67) MMP9MMP1MMP13MMP2SOS1
SCHEMBL1796948 0.85 MMP1 (0.60) MMP9MMP1MMP13MMP2MMP3
SCHEMBL1796951 0.85 MMP1 (0.60) MMP9MMP1MMP13MMP2MMP3
SCHEMBL7468779 0.77 ADAMTS4 (0.69) MMP9MMP1MMP13MMP2MMP3
SCHEMBL6806364 0.77 ADAMTS4 (0.69) MMP9MMP1MMP13MMP2MMP3
SCHEMBL7468791 0.77 ADAMTS4 (0.69) MMP9MMP1MMP13MMP2MMP3
SCHEMBL1903552 0.77 SLC1A3 (0.56) MMP9MMP1MMP13MMP2F2
SCHEMBL27560159 0.77 CA12 (0.54) MMP9MMP1MMP13MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087125-A1 AMINO ACID DERIVATIVES AS INHIBITORS OF MAMMALIAN SODIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2004-10-14 WO disclosed